ClinicalTrials.gg
Sign In

Geographic Atrophy clinical trials

The registry lists 188 studies for Geographic Atrophy across more than 10 countries. 52 are recruiting or about to start. 154 of them are mainly about Geographic Atrophy (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Geographic Atrophy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
82
Recruiting
40
Terminated
24
Active, not recruiting
14
Not yet recruiting
8
Status unknown
8

Phase

Phase 2
75
Phase 1
39
Phase 3
24
Phase 4
7
Early Phase 1
1

Where

United States
131
Australia
41
Germany
40
United Kingdom
38
Spain
32
France
30

Who runs them

Novartis Pharmaceuticals (15) · Apellis Pharmaceuticals, Inc. (9) · Genentech, Inc. (9) · Hoffmann-La Roche (7) · Gyroscope Therapeutics Limited (5) · Alcon Research (5) · Janssen Research & Development, LLC (5) · National Eye Institute (NEI) (5)

What is being tested here

Drugs under test in Geographic Atrophy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pegcetacoplan137
Onzemipgene parvec114
Vonaprument123
ONL1204102
Cemdisiran111
Dapagliflozin101
Pozelimab101
Lampalizumab037
Avacincaptad pegol035
Brolucizumab035

Drug classes tested here Angiogenesis inhibitors 5

Coming up

6phase 3 studies under way
17studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 40 Geographic Atrophy studies recruiting now, 31 (78%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (5%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (10%) take healthy volunteers.

Recruiting studies that take each age, of 40
AgeWomenMen
102 (5%)2 (5%)
187 (18%)7 (18%)
307 (18%)7 (18%)
407 (18%)7 (18%)
5020 (50%)20 (50%)
6540 (100%)40 (100%)
7540 (100%)40 (100%)
8539 (98%)39 (98%)

Across all 188 studies, recruiting or not: 1% stop at 75 or younger and 1% at 65; 3% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Geographic Atrophy studies take

Of 24 phase 2 interventional studies under Geographic Atrophy, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 113 mo8–28 · 13 studies——
Phase 236 mo25–54 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Results posted1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 188. Browse all 188 → or search them.